This inventor holds 3 USPTO granted patents. Top assignees: Government of the United States, The United States of America, The United States of America as Represented by the Department of Health. Active years: 1979-1987.
Company Filing History:
1 out of 22 
1 out of 255 
1 out of 1,217 
Years Active: 1979-1987
Title: The Innovative Contributions of Feng-te Chou
Introduction
Feng-te Chou is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of antitumor agents, holding a total of 3 patents. His work focuses on the development of innovative compounds that have the potential to treat various forms of cancer.
Latest Patents
One of Feng-te Chou's latest patents involves the use of aziridinyl quinones as antitumor agents. This patent discloses a compound known as 2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone, which has shown particular effectiveness in treating various forms of leukemia, B16 melanoma, Lewis lung carcinoma, and the ependymoblastoma brain tumor system. Another patent also highlights the use of aziridinyl quinones against transplanted tumors in mice, further demonstrating the compound's efficacy in several transplanted mouse tumor test systems.
Career Highlights
Feng-te Chou has worked with prominent organizations, including the United States of America and the Government of the United States. His career reflects a commitment to advancing medical science through innovative research and development.
Collaborations
Throughout his career, Feng-te Chou has collaborated with notable individuals such as John S Driscoll and A Hameed Khan. These collaborations have likely contributed to the success of his research and patent developments.
Conclusion
Feng-te Chou's contributions to the field of antitumor agents exemplify the impact of innovative research in medicine. His patents and collaborations highlight his dedication to finding effective treatments for cancer.